/stocks — the workspaceLOADING
Rapport Therapeutics, Inc. (RAPP) is a pharmaceutical preparations company. 16 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-06 from RAPP's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
A plain-English read on RAPP plus an auto-SWOT — built from RAPP's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate RAPP using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Ceesay AbrahamChief Executive Officer | SELL | $327K | view → |
| Gault CherylChief Operating Officer | SELL | $416K | view → |
| Third Rock Ventures V, L.P.10% owner | SELL | $744K | view → |
| Third Rock Ventures V, L.P.10% owner | SELL | $5.4M | view → |
| Third Rock Ventures V, L.P.10% owner | SELL | $11.1M | view → |
| Yeleswaram KrishnaswamyChief Development Officer | SELL | $809K | view → |
| Third Rock Ventures V, L.P.10% owner | SELL | $17.2M | view → |
| Yeleswaram KrishnaswamyChief Development Officer | SELL | $696K | view → |
Projected from RAPP's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment RAPP files its announcement.
RAPP has rallied after 5 of its last 8 earnings reports.
Earnings reactions have been moderate.
RAPP has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+21.0% and -1.9%).
A more typical earnings reaction has been approximately ±1.5%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-07 | +2.6% |
| 2026-03-10 | +0.0% |
| 2025-11-06 | -1.9% |
| 2025-08-07 | -0.4% |
| 2025-05-08 | +0.3% |
| 2025-03-11 | +21.0% |
| 2024-11-07 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +2.1% |
| 2024-08-08 | +1.1% |